Journal of Thrombosis and Thrombolysis

, Volume 46, Issue 4, pp 528–533 | Cite as

Effect of remote ischaemic conditioning on platelet aggregation and platelet turnover

  • Nina Rise
  • Jacobina Kristiansen
  • Anne-Mette Hvas
  • Erik L. Grove
  • Morten Würtz
  • Søs Neergaard-Petersen
  • Steen Dalby KristensenEmail author


Remote ischaemic conditioning (RIC) is a new beneficial treatment for patients with ST-elevation myocardial infarction. RIC may inhibit thrombus formation and, therefore, we investigated whether RIC affects platelet aggregation and turnover. 30 healthy male volunteers were subjected to intervention on day 1 (sham intervention, no aspirin), day 2 (RIC, no aspirin), and day 16 (RIC, treated 7 days with aspirin 75 mg/day). RIC was performed as four cycles of 5 min interchangeable inflation and deflation using an automated cuff. Blood samples were collected 5 min before, as well as 5 and 45 min after RIC. Platelet aggregation was measured by Multiplate® using collagen (COLtest), adenosine diphosphate (ADPtest), and arachidonic acid (ASPItest) as agonists. Platelet turnover was evaluated by flow cytometry. Serum thromboxane B2 was determined by ELISA to confirm aspirin compliance. We found no significant change in platelet aggregation at visit 1 (COLtest: p = 0.32; ADPtest: p = 0.24; ASPItest: p = 0.07), visit 2, except for ADP-induced platelet aggregation evaluated 5 min after RIC (COLtest: p = 0.39; ADPtest: p = 0.02; ASPItest: p = 0.39), or visit 3 (COLtest: p = 0.48; ADPtest: p = 0.61; ASPItest: p = 0.90). Platelet turnover was not influenced by RIC, neither on nor off aspirin (all p-values > 0.07). (1) RIC did not affect platelet aggregation in healthy young men. (2) RIC did not affect platelet turnover in healthy young men. (3) Aspirin did not influence the effect of RIC on platelet aggregation and turnover. (4) Future studies exploring the effect of RIC on platelet aggregation and turnover in patients with ischaemic heart disease are warranted.


Aspirin Ischaemic conditioning Platelet aggregation Platelet function tests Platelet turnover 



We wish to thank laboratory technicians Vivi Bo Mogensen and Mai Stenulm Veirup, Department of Clinical Biochemistry, Aarhus University Hospital, Denmark for laboratory assistance.


The study was supported by The Danish Heart Association, Independent Research Fund Denmark, A.P. Møller Foundation, Helge Peetz og Verner Peetz og hustru Vilma Peetz Foundation, Murermester Lauritz P. Christensen og hustru Kirsten S. Christensens Foundation, Snedkermester Sophus Jacobsen & hustru Astrid Jacobsen Foundation, and Fonden af 17-12-198. The funding sources had no influence on the study design, collection, analysis or interpretation of the data, writing of the manuscript, or the decision to submit the manuscript for publication.

Compliance with ethical standards

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Hausenloy DJ, Yellon DM (2011) The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 8(11):619–629. CrossRefPubMedGoogle Scholar
  2. 2.
    Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Nielsen TT (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375(9716):727–734. CrossRefPubMedGoogle Scholar
  3. 3.
    Sloth AD, Schmidt MR, Munk K, Kharbanda RK, Redington AN, Schmidt M, Pedersen L, Sørensen HT, Bøtker HE (2014) Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J 35(3):168–175. CrossRefPubMedGoogle Scholar
  4. 4.
    Meybohm P, Bein B, Brosteano B, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaette G, Zacharowski K, RIPHeart study collaborators, et al (2015) A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373(15):1397–1407. CrossRefPubMedGoogle Scholar
  5. 5.
    Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Yellon DM et al (2015) Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 373(15):1408–1417. CrossRefPubMedGoogle Scholar
  6. 6.
    Gill R, Kuriakose R, Gertz ZM, Salloum FN, Xi L, Kukreja RC (2015) Remote ischemic preconditioning for myocardial protection: update on mechanisms and clinical relevance. Mol Cell Biochem 402:41–49. CrossRefPubMedGoogle Scholar
  7. 7.
    Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116:674–699. CrossRefPubMedGoogle Scholar
  8. 8.
    Hess DC, Hoda MN, Bhatia K (2013) Remote limb perconditioning and postconditioning: will it translate into a promising treatment for acute stroke?. Stroke 44(4):1191–1197. CrossRefPubMedGoogle Scholar
  9. 9.
    Grove EL, Kristensen SD (2009) Update on oral antiplatelet therapy: principles, problems and promises. Future Cardiol 5(3):247–258. CrossRefPubMedGoogle Scholar
  10. 10.
    Ropcke D, Hjortdal V, Toft G, Jensen M, Kristensen SD (2012) Remote ischemic preconditioning reduces thrombus formation in the rat. J Thromb Haemost 10(11):2405–2406. CrossRefPubMedGoogle Scholar
  11. 11.
    Pedersen CM, Cruden NL, Schmidt MR, Lau C, Bøtker HE, Kharbanda RK, Newby DE (2011) Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans. J Thromb Haemost 9(2):404–407. CrossRefPubMedGoogle Scholar
  12. 12.
    Lordkipanidzé M (2012) Platelet turnover in atherothrombotic disease. Curr Pharm Des 18(33):5328–5343CrossRefPubMedGoogle Scholar
  13. 13.
    Martin JF, Kristensen SD, Mathur A, Grove EL, Choudry FA (2012) The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes. Nat Rev Cardiol 9(11):658–670. CrossRefPubMedGoogle Scholar
  14. 14.
    Grove EL, Hvas AM, Mortensen SB, Larsen SB, Kristensen SD (2011) Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost 9(1):185–191. CrossRefPubMedGoogle Scholar
  15. 15.
    Freynhofer MK, Gruber SC, Grove EL, Weiss TW, Wojta J, Huber K (2015) Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing. J Thromb Haemost 114(3):459–468. CrossRefGoogle Scholar
  16. 16.
    Kristiansen J, Grove EL, Rise N, Neergaard-Petersen S, Würtz M, Kristensen SD, Hvas AM (2016) Effect of remote ischaemic conditioning on coagulation and fibrinolysis. Thromb Res 141:129–135. CrossRefPubMedGoogle Scholar
  17. 17.
    Rubak P, Villadsen K, Hvas AM (2012) Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry. Thromb Res 130(3):420–423. CrossRefPubMedGoogle Scholar
  18. 18.
    Patrono C, Rocca B (2007) Drug insight: aspirin resistance–fact or fashion? Nat Clin Pract Cardiovasc Med 4(1):42–50. CrossRefPubMedGoogle Scholar
  19. 19.
    Pryds K, Kristiansen J, Neergaard-Petersen S, Nielsen RR, Schmidt MR, Refsgaard J, Kristensen SD, Bøtker HE, Grove EL et al (2017) Effect of long-term remote ischaemic conditioning on platelet function and fibrinolysis in patients with chronic ischaemic heart failure. Thromb Res 153:40–46. CrossRefPubMedGoogle Scholar
  20. 20.
    Grove EL, Hvas AM, Johnsen HL, Hedegaard SS, Pedersen SB, Mortensen J, Kristensen SD (2010) A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. J Thromb Haemost 103(6):1245–1253. CrossRefGoogle Scholar
  21. 21.
    Würtz M, Hvas AM, Christensen KH, Rubak P, Kristensen SD, Grove EL (2014) Rapid evaluation of platelet function using the Multiplate® Analyzer. Platelets 25(8):628–633. CrossRefPubMedGoogle Scholar
  22. 22.
    Würtz M, Hvas AM, Kristensen SD, Grove EL (2012) Platelet aggregation is dependent on platelet count in patients with coronary artery disease. Thromb Res 129(1):56–61. CrossRefPubMedGoogle Scholar
  23. 23.
    Weber NC, Riedemann I, Smit KF, Zitta K, van de Vondervoort D, Zuurbier CJ, Hollmann MW, Preckel B, Albrecht M (2015) Plasma from human volunteers subjected to remote ischemic preconditioning protects human endothelial cells from hypoxia-induced cell damage. Basic Res Card 110(2):17. CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Nina Rise
    • 1
    • 2
  • Jacobina Kristiansen
    • 1
    • 2
  • Anne-Mette Hvas
    • 2
    • 3
  • Erik L. Grove
    • 1
    • 3
  • Morten Würtz
    • 1
  • Søs Neergaard-Petersen
    • 1
  • Steen Dalby Kristensen
    • 1
    • 3
    Email author
  1. 1.Department of CardiologyAarhus University HospitalAarhusDenmark
  2. 2.Department of Clinical BiochemistryAarhus University HospitalAarhusDenmark
  3. 3.Department of Clinical Medicine, Faculty of HealthAarhus UniversityAarhusDenmark

Personalised recommendations